Medical News

RSS

Médecins Sans Frontières’ concerns over TPP negotiations

As closed-door talks for the Trans-Pacific Partnership (TPP) Agreement resume in Singapore this week, international medical humanitarian organisation Médecins Sans Frontières is calling on Australia and negotiating countries to reject rules that threaten to dismantle internationally agreed public health safeguards and restrict access to medicines in developing countries.

4 Mar 2013

BioClinica, CPI and Medtentia partner for eClinical and Imaging Core Lab solutions

BioClinica, Inc., a global provider of clinical trial management solutions, today announced an agreement for BioClinica Express EDC, data management, and imaging core lab services with Finnish company Medtentia International, in partnership with the contract research organization (CRO) clinicalprojects international (CPI).

From Clario 4 Mar 2013

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Idera Pharmaceuticals, Inc. today announced the presentation of new data showing that its selective Toll-like receptor antagonists, IMO-3100 and IMO-8400, normalized the gene expression of important cytokines in a preclinical study of skin inflammation that is commonly used as a model of psoriasis.

4 Mar 2013

dailyRx News Network expands Total Patient Engagement solution

The dailyRx News Network, a leading digital publisher of health news, announced today that its Total Patient Engagement solution has been expanded and enhanced to include dailyRx-created video health news.

4 Mar 2013

Horizon forms 3 new Centers of Excellence for gene editing in Asia

Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced it has established three new Centers of Excellence (CoE's) for gene editing in Asia.

4 Mar 2013

CIS now offers Toshiba’s Aplio 500 cardiac ultrasound

Cardiovascular Institute of the South (CIS) now offers its patients the most advanced cardiac ultrasound, thanks to its purchase of 10 Aplio 500s from Toshiba America Medical Systems, Inc.

4 Mar 2013

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.

4 Mar 2013

New intelligent LED driver for mobile phone cameras from ams

ams AG, a leading worldwide designer and manufacturer of high-performance analog ICs for consumer & communications, industrial & medical and automotive applications, today introduced a new intelligent LED driver for mobile phone cameras that maximizes the brightness of the flash without causing the phone's battery to fall below its minimum operating voltage.

4 Mar 2013

Researchers discover new candidate disease proteins for neurodegenerative disorders

A multi-institution group of researchers has found new candidate disease proteins for neurodegenerative disorders.

4 Mar 2013

PsiOxus completes enrollment in MT-102 Phase II trial on cancer cachexia

PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.

4 Mar 2013

Electronic health records increase colorectal cancer screening rates

Researchers used electronic health records to identify Group Health patients who weren't screened regularly for cancer of the colon and rectum-and to encourage them to be screened. This centralized, automated approach doubled these patients' rates of on-time screening-and saved health costs-over two years.

4 Mar 2013

GP consultations: an interview with Associate Professor Helena Britt, University of Sydney

Well it hasn’t varied at all over the last 15 years, which I find pretty amazing because we’ve been through a lot of changes in general practice. Yet, the average length of consultation, as measured from a start to finish time, in a sample of 40,000 consultations in Australia in a year, shows that the average is 15 minutes and the median is 13 minutes.

4 Mar 2013

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

The powerful master regulatory transcription factor called Bcl6 is key to the survival of a majority of aggressive lymphomas, which arise from the B-cells of the immune system. The protein has long been considered too complex to target with a drug since it is also crucial to the healthy functioning of many immune cells in the body, not just B cells gone bad.

4 Mar 2013

Autistic children with severe language delay achieve phrase or fluent speech by age eight

New findings published in Pediatrics (Epub ahead of print) by the Kennedy Krieger Institute's Center for Autism and Related Disorders reveal that 70 percent of children with autism spectrum disorders (ASD) who have a history of severe language delay, achieved phrase or fluent speech by age eight.

4 Mar 2013

Chroma Therapeutics, CTI announce results from tosedostat Phase 2 study on AML

Cell Therapeutics, Inc. (CTI) and Chroma Therapeutics Ltd. announced today that Lancet Oncology has published results from the OPAL Phase 2 study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML).

4 Mar 2013

More than 60% of fire ant allergic patients do not adhere to treatment guidelines

Two million Americans are allergic to insect stings, an allergy which sends more than 500,000 people to the emergency room annually. Yet, according to a study published today in the March issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAA), while fire ant allergy sufferers know allergy shots can save their life, more than 60 percent do not adhere to treatment guidelines.

4 Mar 2013

Scientists produce new instruction manual for human genome

Scientists have produced an instruction manual for the human genome that provides a framework to better understand the relationship between an individual's genetic make-up and their lifestyle.

From The University of Manchester 4 Mar 2013

DBV Technologies total revenues increase to €2,776,588 for full year 2012

DBV Technologies, creator of Viaskin, a new standard in the treatment of allergy, announced today its full year 2012 results, approved by the Board of Directors on March 1st, 2013.

4 Mar 2013

Children with ADHD more likely to have other psychiatric disorders as adults

The first large, population-based study to follow children with attention-deficit hyperactivity disorder (ADHD) into adulthood shows that ADHD often doesn't "go away," and that children with ADHD are more likely to have other psychiatric disorders as adults. Although numbers were small, they also appear more likely to commit suicide and are often incarcerated as adults.

4 Mar 2013

Older patients with head and neck cancers less likely to die in high-volume hospitals

A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced their survival.

4 Mar 2013

Medical News

Médecins Sans Frontières’ concerns over TPP negotiations

BioClinica, CPI and Medtentia partner for eClinical and Imaging Core Lab solutions

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

dailyRx News Network expands Total Patient Engagement solution

Horizon forms 3 new Centers of Excellence for gene editing in Asia

CIS now offers Toshiba’s Aplio 500 cardiac ultrasound

Positive results from NeuroDerm ND0612 Phase I trial on Parkinson's

New intelligent LED driver for mobile phone cameras from ams

Researchers discover new candidate disease proteins for neurodegenerative disorders

PsiOxus completes enrollment in MT-102 Phase II trial on cancer cachexia

Electronic health records increase colorectal cancer screening rates

GP consultations: an interview with Associate Professor Helena Britt, University of Sydney

Study finds how to shut down Bcl6 in diffuse large B-cell lymphoma

Autistic children with severe language delay achieve phrase or fluent speech by age eight

Chroma Therapeutics, CTI announce results from tosedostat Phase 2 study on AML

More than 60% of fire ant allergic patients do not adhere to treatment guidelines

Scientists produce new instruction manual for human genome

DBV Technologies total revenues increase to €2,776,588 for full year 2012

Children with ADHD more likely to have other psychiatric disorders as adults

Older patients with head and neck cancers less likely to die in high-volume hospitals

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News